Peer Review History

Original SubmissionJuly 7, 2022
Decision Letter - Elena G. Tolkacheva, Editor

PONE-D-22-19009Action Potential Metrics and Automated Data Analysis Pipeline for Cardiotoxicity Testing Using Optically Mapped hiPSC-derived 3D Cardiac MicrotissuesPLOS ONE

Dear Dr. Choi,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please address all comments indicated by the Reviewers.

Please submit your revised manuscript by Dec 01 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Elena G. Tolkacheva, PhD

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: I Don't Know

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: In this manuscript, Arvin H et al. developed automated data processing algorithms to assess changes in AP properties for cardiotoxicity testing in 3D engineered cardiac microtissues generated from hiPSC-CMs. This simple and robust automated data analysis pipeline for evaluating key AP metrics provides an excellent in vitro cardiotoxicity testing platform for a wide range of environmental and pharmaceutical compounds. Overall, the subject and perspective are novel and valuable for reference. However, to make the review more rigorous and complete, some points must be concerned:

Major comments

1. In this manuscript, 3D organoid is composed by hydrogel aggregation, and whether the established detection system is also suitable for the detection of 3D organoid action potentials in non-hydrogel media or non-conduction media.

2. The layout of the chart can be more optimized and neat . For example, ①-⑤ should be marked in Figure1; A can be directly represented in Figure2 and Fig2.D can be divided into D-G, ect .

3. In the method part, the writing should be standard and paragraphs should be formatted. For example, "Error! Reference source not found”, “ A shows” ,etc.

4. Is the ordinate unit (#) in Figure4?

5. The manuscript needs an in-depth review by grammar and spelling with a native speaker.

Reviewer #2: In this study, the authors perform automated optical mapping and analysis to extract action potential metrics and assess cardio toxicity. Though this is an interesting study and an important endeavor. I have several major comments that must be addressed prior to the acceptance of this manuscript.

Major Comments

1. All code and relevant example data should be provided on GitHub or similar. At present, code snippets are included within a word doc in the supplementary materials of this manuscript. Instead, these functions should be in “.py” files and stored and disseminated on a public GitHub page or similar platform that is designed for sharing code.

2. In addition to sharing the code as “.py” files, the authors should include full information needed to run both the simulations and analysis code. Specifically, this will require choosing a strategy to share the correct python packages (e.g., requirements.txt file, pyproject.toml file) and installation instructions. And, the authors should provide instructions for running both the simulation code and the analysis software, ideally in the form of a brief tutorial.

3. One key element missing from the paper is a discussion + quantitative comparison of how these techniques compare to recent open source alternatives shared in the literature. As one (of many) potential examples that should be used for direct comparison, the open source software KairoSight seems to provide similar functionality (e.g., https://github.com/kairosight/kairosight-2.0 and https://www.frontiersin.org/articles/10.3389/fphys.2021.752940/full). The authors should create a table with results from direct comparisons between their proposed methods and alternatives currently used in the literature.

4. On p. 8 in the section “Multi-class logistic regression and principal components analysis” — I encourage the authors to double check a few things and to make sure that they are clear. Specifically: (a) Was the standard scalar fitted using the whole dataset or the training dataset? (b) Was all hyper parameter tuning done by examining validation data specifically? Based on the description on page 9 line 237 I am concerned that there is overfitting to the small experimental dataset. For reference, k-fold cross validation must still have held out test data if the ith fold is being used for hyper parameter and/or model selection. Providing the datasets + scripts in a tutorial format on GitHub or similar will greatly increase my confidence in this part of the work.

Minor Comments

1. Page 7 line 159: Error! Reference source not found

2. Page 8 line 186: Error! Reference source not found

3. Funding sources listed in the manuscript vs. on the cover page are inconsistent

4. Are all figures and figure panels referenced in the main body of the paper? It is hard to keep track especially with the error in referencing.

5. Many of the figures are pixelated — this should be addressed.

6. The figure color scheme should be adjusted to be friendly to readers with red/green colorblindness.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

We thank reviewers for the insightful reviews and careful consideration of our manuscript. We found both the general and specific comments extremely helpful in making revisions. We have made several key changes to our manuscript based on reviewers’ critique; 1) we added quantitative comparison between traditional signal processing vs. new routines optimized for simultaneous fluorescence recordings from multiple microtissues, 2) high resolution figures were generated, 3) the color scheme of plots were modified to assist readers with colorblindness, 4) the manuscript was reviewed by native speakers and grammatical and spelling mistakes were corrected. Our point-by-point responses are available in the response to reviewers.

Attachments
Attachment
Submitted filename: PLoS One Reponse to Reviewer - Cardiac AP Algorithm Paper.pdf
Decision Letter - Elena G. Tolkacheva, Editor

Action Potential Metrics and Automated Data Analysis Pipeline for Cardiotoxicity Testing Using Optically Mapped hiPSC-derived 3D Cardiac Microtissues

PONE-D-22-19009R1

Dear Dr. Choi,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Elena G. Tolkacheva, PhD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: I Don't Know

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors developed the automated data processiong algorithms to access action potential in 3D EHT from hiPSC-CMs. They have solved the issued in current version.

Reviewer #2: Thank you to the authors for engaging with the peer review process. Thought I cannot access the GitHub link at present, I trust that the authors will make it public + include detailed documentation for their datasets and code as promised. If this is not published in a timely manner I do not support the publication of this manuscript.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

Formally Accepted
Acceptance Letter - Elena G. Tolkacheva, Editor

PONE-D-22-19009R1

Action Potential Metrics and Automated Data Analysis Pipeline for Cardiotoxicity Testing Using Optically Mapped hiPSC-derived 3D Cardiac Microtissues

Dear Dr. Choi:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Elena G. Tolkacheva

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .